Lefradafiban, formerly known as BIBU-104, is a glycoprotein IIb/IIIa receptor antagonist potentially for the treatment of thrombosis. References: Kostewicz ES, Wunderlich M, Brauns U, Becker R, Bock T, Dressman JB. Predicting the precipitation of poorly soluble weak bases upon entry in the small intestine. J Pharm Pharmacol. 2004 Jan;56(1):43-51. PubMed PMID: 14980000.

纯度：≥98%

CAS：149503-79-7